Covid-19 Vaccination Resource

CDC, FDA, DSHS RECOMMEND PAUSE ON
JOHNSON & JOHNSON VACCINE

Updated 4/14/21:

Six people out of the millions who have received the Johnson & Johnson/Janssen COVID-19 vaccine in the United States developed a rare and severe type of blood clot between 6 and 13 days after vaccination. Right now, these adverse events appear to be extremely rare and are being further evaluated to ensure vaccine safety.

The Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and DSHS are recommending providers temporarily pause administering the Johnson & Johnson COVID-19 vaccine as that evaluation is done.

There is no evidence of a similar concern with the Pfizer and Moderna COVID-19 vaccines. DSHS strongly encourages people to get the Pfizer and Moderna vaccines since vaccination is the best way to control cases of COVID-19 and end the pandemic.

If you experience severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination, please contact your healthcare provider for information on what you should do next.

For more info, click here.

(source: dshs)

VACCINE ELIGIBILITY IN TEXAS

The Texas Department of State Health Services announced that starting Monday, March 29, All Texas adults will be eligible for the COVID-19 vaccine.

Vaccine supply is excepted to increase. Next week, DSHS will launch a registration website and toll-free number for some public health vaccine clinics.

For more info, click here.

(source: dshs)

Playlist